Article

Ensuring The Greatest Return From Your Poorly Soluble Molecule

Source: Thermo Fisher Scientific

By Marshall Crew, SVP Innovation, Patheon

Ensuring The Greatest Return From Your Poorly Soluble Molecule

Currently, about 70% of new molecular entities (NMEs) exhibit poor solubility in water and require some form of enhancement in order to achieve sufficient bioavailability, leading to tough questions about how to proceed for biopharmaceutical companies developing such compounds.

The sheer number of potential strategies for improving the solubility of a compound — which include various methods of particle size reduction, solid dispersions, salt formation, lipid formulations, inclusion complexes, nanocrystals, and a wide variety of other technologies — can overwhelm many developers, leaving them unsure how to choose a path forward.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: